Neuromuscular
Block Guide
Need for Blockade
Monitoring
Dosing Principles
Drug Selection Principles
Drug Selection Specifics
Drug Pharmacology
Antagonism
Prices
Home-Amb-Card-Crit-Neuro-OB-Orth-Pain-Ped-Reg-Tran-Vasc-Misc
(based on Hugh Grant's page - see original for references,
etc.)
Need for Neuromuscular Blockade
| Not Needed: |
Integumentary, Breast |
| Intermittent: |
Intra-abdom, Intra-thoracic, Intracranial |
| Profound: |
Open Eyes |
Back to Top of Page
Monitoring
1. Monitoring of thumb is preferred
-
ulnar nerve at wrist
-
vis/palp assessment of thumb adduction
-
train-of-four; counting twitches = train-of-four count
-
T1, T2, T3, T4
2. Administration of MR should be based on clinical indications
and guided by assessment of response to neuromuscular monitoring
3. Train-of-four should be checked prior to administration
of NDMR (to detect prolonged response to succinylcholine)
4. Optimal relaxation (assuming adequate background
anesthetic) = T1-T2 present in train-of-four count
5. Knowledge of
-
ED95 (anesthesia background dependent)
-
onset time
-
duration
6. The deeper the block, the tougher it is to antagonize
(see antagonism algorithm, chart #2)
-
T0 = unantagonizable block
-
T1 only = antagonizable but difficult, drug dependent (pan, dtc, meto,
longer than cis/roc/atr/vec) and takes 12-20 min
-
T1, T2 present = antagonizable
-
T1, T2, T3 or T1, T2, T3, T4 present = easily antagonizable
7. Detecting adequate reversal is difficult
-
measured train-of-four best > DBS "no fade" > train-of-four "no fade"...
others unreliable.
-
If in question, use clinical criteria: sustained head-lift x 5 sec, sustained
hand grasp x 5 sec, sustained masseter muscle strength, or maximum NIF
>= 50 cmH20 (i.e., more negative). 5-sec leg lift in pediatric patients.
% Receptors
Occupied |
Response to
Nerve Stim |
Signs |
| 99-100 |
None |
Flaccid; rarely needed |
| 95 |
PTF present |
Diaphragm moves; hiccough possible |
| 90 |
TOF = 1/4 |
Abd relaxation adequate for most procedures |
| 75 |
T1 = 100% baseline
TOF = 4/4
T4:T1 = 0.7
50-Hz tetanus sustained |
TV, VC normal |
| 50 |
100-Hz tetanus sustained |
Passes NIF test (?) |
| 30 |
200-Hz tetanus sustained |
Head-lift, hand grip sustained |
Back to Top of Page
Dosing:
-
Need to know ED95, onset time, duration of relaxation (see
pharmacology)
-
Give ED95 x 1 initially (assuming patient already intubated using sux)
-
Wait duration of onset time, check train-of-four count
-
If train-of-four count > 2 at onset time dose ED95 x 1 again
-
Titrate drug to therapeutic window (T1-T2 present only) during period of
required relaxation
-
Allow as much recovery as possible prior to antagonism of block
-
Antagonize block with neostigmine 0.04-0.07 mg/kg + glycopyrrolate 0.01
mg/kg
-
Use of volatile anesthetics reduce the requirement for neuromuscular blocking
drugs in a dose-related fashion (1 MAC reduces ED95 by approx 1/3)
Back to Top of Page
Drug Selection Principles
-
In the elderly, those with impaired renal function, and/or complicated
metabolic/electrolyte profile a drug which is independent of organ (kidney
or liver) elimination is preferable (cisatracurium).
-
Residual NMB in PACU increases portential for aspiration, hypoxia and other
postop pulmonary complications
-
Patient criteria: Age, renal function
-
Indication of rapid sequence when sux contraindicated
-
Case duration, extubation plans.
-
Cost
-
Liver disease is not considered a clinically meaningful selection criteria.
If severe liver disease, cisatracurium is probably best.
-
Potential cardiovascular effects are not a clinically meaningful drug selection
criteria. They are, however, important dosing considerations.
There is a dynamic interaction between drug cost,
weight of patient, and duration of relaxation needed. The table below demonstrates
this interaction (it assumes intubation after 2x ED95 of the drug and standard
top-up regimens given at the appearance of the third twitch in the train-of-four):
Prices are based on October 1999 UNC.
| Drug |
Duration (70 kg) |
$ cost/ vial |
$ cost/ min |
| vec |
90 min |
7.84 |
0.09 |
| atra |
145 min |
12.39 |
0.09 |
| panc |
140 min |
1.26 |
0.01 |
| miv |
36 min |
19.27 |
0.54 |
| roc |
43 min |
11.22 |
0.26 |
| cis |
135 min |
13.66 |
0.10 |
This is biased toward quantal use (e.g. opening a second vial of drug doubles
the cost). The durations noted reflect complete use on one vial of drug.
Alternative packaging and administration techniques can diminish waste
of subsequent vials of drug while ensuring regard for sterility and prevention
of disease transmission.
Back to Top of Page
Drug Selection Guidelines
-
when duration of relaxation needed is longer than 1 hour
-
when extubation is not planned immediately post-op
-
when renal function is normal
-
when patient < 70 years old
-
when no comorbidity factors are present. This incorporates the data that
suggests the immediate-acting (duration drugs) are more easy to reverse
than pancuronium.
-
presence of renal failure
-
> 70 years old
-
when complete reversal of NMB is absolutely essential at end of case (e.g.
full stomach, morbid obesity, difficult airway, etc.)
-
duration of case 35-60 minutes
-
when complete reversal of NMB is absolutely essential at end of case (e.g.
full stomach, morbid obesity, difficult airway, etc.)
-
duration of case 35-60 minutes
-
profound relaxation needed in case no longer than 35 minutes
-
a succinylcholine drip, made by combining 5 (20mg/cc x 10cc) bottles is
another valid alternative to mivacurium
-
when succinylcholine is contraindicated
-
when complete reversal of NMB is absolutely essential at end of case (e.g.
full stomach, morbid obesity, difficult airway, etc.)
-
d-tubocurarine - can be used to prevent fasciculations induced by succinylcholine
when administered 3 to 5 minutes prior to the dose of succinylcholine
The following drugs have not been deemed to have clinical value our operating
room:
-
doxacurium
-
gallamine
-
metocurine
-
pipecuronium
Back to Top of Page
Antagonism of Neuromuscular Blockade
-
ALL NDMR's SHOULD BE PHARMACOLOGICALLY REVERSED BEFORE EXTUBATION (with
possible exception of mivacurium)
-
The most reliable signs of adequate restoration of neuromuscular function
are CLINICAL signs: 5-sec head lift, 5-sec hand grasp, sustained masseter
muscle strength, maximum NIF >= 50 cmH20 (i.e., more negative)
-
No twitches present in the TOF Count represents an unantagonizable block
-
Deeper blocks (e.g. T1 only present) are more difficult to antagonize than
blocks where T2, T3 or T4 twitches are present in TOF Count
-
To maximize muscle recovery, reversal ought not be given till TOF Count
is at least 2.
-
Longer-acting muscle relaxants (e.g. panc, curare, meto) are not as readily
antagonized as intermediate or short duration muscle relaxants (e.g. vec,
atra, roc, miv)
-
Neostigmine is more effective in antagonizing deep blocks
-
"No detectable fade" of DBS (Double Burst Stimulation) is the most reliable
twitch monitoring sign of adequate restoration of neuromuscular function
-
Combining knowledge of # of twitches in TOF Count present at time of reversal,
the relaxant being antagonized and time since reversal can enhance the
accuracy of detecting adequate restoration of neuromuscular function
Back to Top of Page
NDMR Pharmacology
| Drug |
Potency* |
ED95
(mg/kg) |
Duration
ED95 (min) |
Cardiovascular Effects |
Elimination |
| Pancuronium |
1 |
0.07 |
~60 |
HR, BP |
60% kidney 40% liver |
| Gallamine |
0.025 |
2.8 |
~60 |
HR, BP |
100% kidney |
| Curare |
0.14 |
0.5 |
~60 |
Histamine release ¯BP,
ganglionic blockade |
40% kidney 60% liver |
| Metocurine |
0.25 |
0.28 |
~60 |
1/3 histamine of curare ¯BP,
ganglionic block |
60-90% kidney |
| Vecuronium |
0.9 |
0.056 |
~25 |
None |
50% liver 20% kidney |
| Atracurium |
0.25 |
0.26 |
~25-30 |
1/3 histamine of curare ¯BP |
Nonspecific plasma esterases,
Hoffmann elimination |
| Mivacurium |
0.875 |
0.08 |
~19 |
similar to atracurium |
Hydrolysis: plasma cholinesterase |
| Doxacurium |
2.3 |
0.03 |
~60 |
minimal ¯BP |
~50% kidney |
| Pipecuronium |
1.4 |
0.05 |
~60 |
None |
75% kidney |
| Rocuronium |
0.23 |
0.3 |
~25-30 |
None, ? HR |
~ 50% liver ~ 20% kidney |
| Cisatracurium |
1.4 |
0.05 |
~25-30 |
None |
Hoffmann elimination |
*potency comparisons are to pancuronium 1 mg, ED95 is the estimated dose
to produce 95% depression of twitch height. Duration ED95 is the time from
injection until the T4/T1 ratio is 70% after a 1x ED95 dose.
Back to Top of Page